NovoCure

NovoCure is an oncology medical-device company commercializing Tumor Treating Fields, a proprietary platform that uses electric fields to disrupt cancer-cell division. It generates revenue from direct sales and treatment-related services, as well as licensing and product-supply arrangements such as its agreement with Zai Lab in Greater China.

Relationship details are part of the Pro plan.